Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Dr. Treat
AddedMar 17, 2024
UpdatedJul 7, 2026
Dr. Treat

Dr. Treat

Seed

Tech-driven vet care for pets.

Founded
2021
Accelerator
Y Combinator logoY CombinatorS22
Overview
Compare
Fundraising
Employees
Website

Dr. Treat, founded with a mission to revolutionize veterinary care, offers both virtual and in-clinic services for pets. The company aims to become the largest pet health provider by leveraging technology and data to deliver personalized and preventative care. Their services are designed to cater to the modern pet parent, ensuring convenience and comprehensive health management for pets.

Notable figures associated with Dr. Treat include experts in veterinary medicine and technology, though specific names are not provided. The company has achieved significant milestones in expanding its service offerings and integrating advanced tech solutions into pet care. Dr. Treat's impact is evident in its growing customer base and positive reception among pet owners seeking modern, efficient veterinary solutions.

Dr. Treat - Similar Companies

Treat logo

Treat

VetPronto logo

VetPronto

Dr.Tail logo

Dr.Tail

drtail.us

Petriage logo

Petriage

petriage.com

Petfolk logo

Petfolk

petfolk.com

Dutch logo

Dutch

dutch.com

BoosterPet logo

BoosterPet

boosterpet.com

Vet On Demand logo

Vet On Demand

Bond Vet logo

Bond Vet

bondvet.com

DailyDoctor logo

DailyDoctor

mydailydoctor.com

VetRec logo

VetRec

vetrec.io

Dr.Online logo

Dr.Online

dronline.com

KwikVet logo

KwikVet

kwikvet.com

VetX logo

VetX

DrHouse logo

DrHouse

drhouse.com

Dr. Treat - Quick Facts

Who are Dr. Treat's competitors?

Companies similar to Dr. Treat include Treat, VetPronto, Dr.Tail and Petriage.

When was Dr. Treat founded?

Dr. Treat was founded in 2021.

When was Dr. Treat's last funding round?

Dr. Treat's most recent funding round was for $500k (USD) in June 2022.

How much has Dr. Treat raised to-date?

As of Jun 1, 2022, Dr. Treat has raised a total of $500k (USD).

How many employees does Dr. Treat have?

Dr. Treat has 21 employees as of Aug 23, 2023.